Phase I study of 68Ga-HER2-Nanobody for PET/CT assessment of HER2-expression in breast carcinoma
Keyaerts, M., Xavier, C., Heemskerk, J., Devoogdt, N., Everaert, H., Ackaert, C., Vanhoeij, M., Duhoux, F. P., Gevaert, T., Simon, P., Schallier, D., Fontaine, C., Vaneycken, I., Vanhove, C., De GreveLanguage:
english
Journal:
Journal of Nuclear Medicine
DOI:
10.2967/jnumed.115.162024
Date:
October, 2015
File:
PDF, 1.04 MB
english, 2015